Delivery Order SPE2DB22D3401-SPE2DB25FT5FK
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on July 29, 2025, for Bridion 500 mg/5 mL vials, with a ceiling value of $35,252.62 under firm fixed-price terms. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This competitively awarded, non-set-aside delivery order is...
- The Defense Logistics Agency awarded a $49,205.91 delivery order to AmerisourceBergen Drug Corp on October 8, 2025, for the supply of Bridion 500 mg/5 mL vials. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of October 9, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $60,425.21 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 mL vials on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Bridion 200 mg/2 ml vials with a ceiling value of $13,804.03. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, was competitively awarded with no set-aside designation. Performance of the order is to be fulfilled...
- The Defense Logistics Agency awarded a delivery order valued at $13,449.57 to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 mL vials on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price, non-set-aside contract will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $39,774.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Bridion 500 mg/5 mL vials. The contract represents a non-competitive delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vehicle serves as a comprehensive global pharmaceutical support contract enabling...
- The Defense Logistics Agency awarded a delivery order valued at $37,940.60 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Bridion 500 mg/5 mL vials. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract falls under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Bridion 200 mg/2 mL vials totaling $2,544.38 with a completion date of August 26, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order structure, with performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's substantial Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 21, 2025, for the supply of Bridion 200mg/2ml (10 units) with a ceiling value of $24,536.83. This firm fixed-price, competitively awarded delivery order is funded by the Defense Logistics Agency's Medical Supply Chain division and is scheduled for completion by August 15, 2025. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $4,176.87 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Bridion 200 mg/2 mL vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 25, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award represents a single transaction within AmerisourceBergen's broader...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT5FKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,070.80 to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 mL vials on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitive award utilizes firm fixed pricing with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates capability in delivering a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for Bridion, a neuromuscular blockade reversal agent, reflects the company's ongoing role in supplying specialized pharmaceutical products necessary for military medical operations and healthcare support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/18/25 |